Additional information
Off white Powder (Hygroscopic)
1190105-63-5
ACI-181304
1-[3?-Acetoxy-17?-hydroxy-2?-(morpholin-4-yl)-5?-androstan-16?-yl]-1-(prop-2-enyl) pyrrolidinium bromide
1-[(2?,3?,5?,16?,17?)-3-(Acetyloxy)-17-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propen-1-yl)-pyrrolidinium Bromide
192.9-193.1°C
C32H53BrN2O4
609.68
Ambient
2-8°C
3-Acetyl-17-deacetyl Rocuronium Bromide
Neuromuscular blocking agent


			
			
			
			
![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)